Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Aravindabharathi Ramakrishnan, PhD
Dr. Aravindabharathi Ramakrishnan is exploring how cancers exploit the TGF-β1 pathway for protection, so that he can… -
CRI Funded Scientist
Randall S. Carpenter, PhD
Dr. Randall S. Carpenter is exploring how a potential link between nerves and reactive oxygen species (ROS)… -
CRI Funded Scientist
Renan V. H. de Carvalho, PhD
Dr. Renan V. H. de Carvalho is defining the mechanisms that enable B cells to mature into… -
CRI Funded Scientist
Samuel A. Rose, PhD
Dr. Samuel A. Rose is examining the mechanisms through which regulatory T cells (Tregs) suppress immune responses… -
CRI Funded Scientist
Brian Ruffell, PhD
Dendritic cells are a rare population of immune cell responsible for controlling how the adaptive immune system… -
CRI Funded Scientist
Ilia Kurochkin, PhD
Dr. Ilia Kurochkin is deciphering the regulatory networks that govern cell identity and function in order to… -
CRI Funded Scientist
Samuel C. Markson, PhD
Dr. Markson is investigating age-related changes in “killer” T cells and how that influences our ability to… -
CRI Funded Scientist
Maxime Meylan, PhD
Dr. Maxime Meylan is exploring how the spatial organization of different cells within breast cancers affects the… -
CRI Funded Scientist
Xiaoyang Wu, Ph.D.
Dr. Xiaoyang Wu is developing a novel drug delivery system to improve the effectiveness of cancer immunotherapy…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.